Literature DB >> 22170713

Tight glycemic control may increase regenerative potential of myocardium during acute infarction.

Raffaele Marfella1, Ferdinando Carlo Sasso, Federico Cacciapuoti, Michele Portoghese, Maria Rosaria Rizzo, Mario Siniscalchi, Ornella Carbonara, Franca Ferraraccio, Michele Torella, Antonello Petrella, Maria Luisa Balestrieri, Paola Stiuso, Giannantonio Nappi, Giuseppe Paolisso.   

Abstract

AIMS: We analyzed the effects of tight glycemic control on regenerative potential of myocardium during acute myocardial infarction. PATIENTS AND METHODS: Seventy-five patients with their first acute myocardial infarction undergoing coronary bypass surgery were studied: 25 patients with glycemia below 140 mg/dl served as the control group; hyperglycemic patients (glucose>140 mg/dl) were randomized to intensive glycemic control (IGC; n=20; glucose goal, 80-140 mg/dl), conventional glycemic control (CGC; n=20; glucose goal, 180-200 mg/dl), or glucose-insulin-potassium (GIK; n=10; glucose goal, 180-200 mg/dl) for almost 3 d before surgery, using insulin infusion followed by sc insulin treatment. During surgery, myocyte precursor cells (MPC) (c-kit/MEFC2/GATA4-positive cells), oxidation of MPC DNA (c-kit/8-hydroxydeoxyguanosine-positive cells), senescent MPC (c-kit/p16INK4a-positive cells), and cycling cardiomyocytes (Ki-67-positive cells) were analyzed in biopsy specimens taken from the peri-infarcted area. RESULTS AND DISCUSSION: Before surgery, plasma glucose reduction was greater in the IGC group than in the CGC and GIK groups (P<0.001 for both). IGC patients had higher MPC (P<0.01) and cycling myocytes (P<0.01), as well as less oxidized (P<0.01) and senescent MPC (P<0.01) in peri-infarcted specimens compared with both CGC and GIK patients. Tight glycemic control, by reducing senescent MPC, may increase regenerative potential of the ischemic myocardium.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22170713     DOI: 10.1210/jc.2011-2037

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  31 in total

1.  Acute coronary syndromes: Early metabolic modulation--a solution for MI?

Authors:  Iwan C C van der Horst
Journal:  Nat Rev Cardiol       Date:  2012-05-22       Impact factor: 32.419

Review 2.  Pharmacological Strategies to Retard Cardiovascular Aging.

Authors:  Irene Alfaras; Clara Di Germanio; Michel Bernier; Anna Csiszar; Zoltan Ungvari; Edward G Lakatta; Rafael de Cabo
Journal:  Circ Res       Date:  2016-05-13       Impact factor: 17.367

3.  Tumor Necrosis Factor Receptor Superfamily Member 21 Induces Endothelial-Mesenchymal Transition in Coronary Artery Endothelium of Type 2 Diabetes Mellitus.

Authors:  Po-Chao Hsu; Jiun-Chi Huang; Wei-Chung Tsai; Wei-Wen Hung; Wei-An Chang; Ling-Yu Wu; Chao-Yuan Chang; Yi-Chun Tsai; Ya-Ling Hsu
Journal:  Biomedicines       Date:  2022-05-30

4.  Annexin A1 induces skeletal muscle cell migration acting through formyl peptide receptors.

Authors:  Valentina Bizzarro; Raffaella Belvedere; Fabrizio Dal Piaz; Luca Parente; Antonello Petrella
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

5.  Annexin A1 N-terminal derived peptide Ac2-26 stimulates fibroblast migration in high glucose conditions.

Authors:  Valentina Bizzarro; Bianca Fontanella; Anna Carratù; Raffaella Belvedere; Raffaele Marfella; Luca Parente; Antonello Petrella
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

Review 6.  Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects.

Authors:  Giuseppe Palmiero; Arturo Cesaro; Erica Vetrano; Pia Clara Pafundi; Raffaele Galiero; Alfredo Caturano; Elisabetta Moscarella; Felice Gragnano; Teresa Salvatore; Luca Rinaldi; Paolo Calabrò; Ferdinando Carlo Sasso
Journal:  Int J Mol Sci       Date:  2021-05-30       Impact factor: 5.923

Review 7.  Targeting senescent cells to attenuate cardiovascular disease progression.

Authors:  Ping Song; Qiang Zhao; Ming-Hui Zou
Journal:  Ageing Res Rev       Date:  2020-04-13       Impact factor: 10.895

Review 8.  The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms.

Authors:  Teresa Salvatore; Pia Clara Pafundi; Raffaele Galiero; Gaetana Albanese; Anna Di Martino; Alfredo Caturano; Erica Vetrano; Luca Rinaldi; Ferdinando Carlo Sasso
Journal:  Front Med (Lausanne)       Date:  2021-06-30

9.  Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes.

Authors:  Raffaele Marfella; Ferdinando Carlo Sasso; Maria Rosaria Rizzo; Pasquale Paolisso; Michelangela Barbieri; Vincenzo Padovano; Ornella Carbonara; Pasquale Gualdiero; Pasquale Petronella; Franca Ferraraccio; Antonello Petrella; Raffaele Canonico; Ferdinando Campitiello; Angela Della Corte; Giuseppe Paolisso; Silvestro Canonico
Journal:  Exp Diabetes Res       Date:  2012-11-01

10.  The association between glycaemic control during hospitalization and risk of adverse events: A retrospective cohort study.

Authors:  Lan Deng; Wusiman Aibibula; Zahra Talat; Kristian B Filion; Shaun Eintracht; Kaberi Dasgupta; Vicky Tagalakis; Agnieszka Majdan; Oriana Hoi Yun Yu
Journal:  Endocrinol Diabetes Metab       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.